Resource
-
LanguageEnglish
-
Resource TypeOther
-
Uploaded By
-
Date Added2017-03-15
-
Corporate AuthorshipAdnan Ziadat and Iyad Nino/ Al-Jidara Investment Services
-
Collections
-
Related Resources
Firm Level Management and Technical Assistance to MonoJo
Communications
Economic growth and development
Financial management
Private sector
Training Material
Technical Document
Regulations
Organizational structure
Pricing
Medical Sector
MonoJo was established in 2005 as a private shareholding company, focused on developing
and producing monoclonal antibodies for cancer diagnostics, targeting local and regional
markets. Currently, the Company has 20 cancer diagnostics antibodies in the pipeline, five
almost ready for market, while 15 others still under development. MonoJo is planning to
develop and distribute diagnostic kits as an added value product and source of additional
revenues.